已收盘 09-19 16:00:00 美东时间
-0.031
-20.18%
With Proportional Adjustments To Warrants, Stock Options, And Convertible Preferred Stock
09-19 20:34
Reshape Lifesciences (NASDAQ:RSLS) reported quarterly losses of $(0.06) per share. This is a 94.44 percent increase over losses of $(1.08) per share from the same period last year. The company reported quarterly sales
08-15 04:11
ReShape Lifesciences® Reports Second Quarter Ended June 30, 2024 Financial Resu...
08-15 04:05
ReShape Lifesciences® to Announce Financial Results for the Second Quarter Ende...
08-13 20:31
Maxim Group analyst Anthony Vendetti downgrades Reshape Lifesciences (NASDAQ:RSLS) from Buy to Hold.
07-17 21:45
Vyome Therapeutics- Has Signed a Merger Agreement With ReShape Lifesciences
07-10 00:13
ReShape Lifesciences (RSLS) has shared an update. ReShape Lifesciences Inc. is ...
07-09 21:48
Shares of ReShape Lifesciences (NASDAQ:RSLS) climbed in the premarket Tuesday after the medical device maker reached a merger agreement to combine with privately held specialty pharma company Vyome Th...
07-09 21:02
ReShape Lifesciences Inc - Existing Co Stockholders to Own 11.1% of Combined Co...
07-09 20:31